(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Inhibition of ID4 prevents the effects of BMP4 on glial lineage commitment.
The effectiveness of inhibition of Id4 expression by RNAi was
confirmed by RT-PCR (A) and quantitative RT-PCR (B) using mRNA extracted from
E17 progenitor cells treated with BMP4 (20 ng/ml) for 12 hours and infected
with lentivirus containing empty vector (green in B) or Id4-RNAi
constructs (blue in B). The graphs shown are representative of experiments
done in duplicate three times. (C) E17 progenitor cells infected with
lentivirus containing empty vector (parts a-f) or Id4-RNAi (parts
g-l) were grown with (parts d-f,j-l) or without (parts a-c,g-i) BMP4 (20
ng/ml) for 2 days. Cells were stained for CNPase, MBP and GFAP. DAPI was used
as a nuclear stain and virus-infected cells were identified by staining for
GFP. (D) Quantification of CNPase+, GFAP+ and
ß-tubulinIII+ cells shows increased numbers of OLs with
Id4-RNAi. Scale bars represent means±s.e.m. of four
independent experiments. ANOVA was done to determine significance
(P<0.05). The control (vector alone) group differed significantly
from both BMP4-treated and Id4-RNAi groups with respect to CNPase and
GFAP, but did not differ from the group treated with both BMP4 and
Id4-RNAi. The BMP4-treated and Id4-RNAi-treated groups each
differed from all other groups with respect to CNPase and GFAP. There were no
significant differences among groups with respect to ß-tubulinIII.